- 全部删除
您的购物车当前为空
FT895 是一种具有选择性和有效性的 HDAC11 抑制剂,具有抗真菌和抗肿瘤活性,抑制 HDAC11 表达,限制 EV71在体外复制。


为众多的药物研发团队赋能,
让新药发现更简单!
FT895 是一种具有选择性和有效性的 HDAC11 抑制剂,具有抗真菌和抗肿瘤活性,抑制 HDAC11 表达,限制 EV71在体外复制。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 816 | In stock | |
| 5 mg | ¥ 1,980 | In stock | |
| 10 mg | ¥ 2,930 | In stock | |
| 25 mg | ¥ 4,850 | In stock | |
| 50 mg | ¥ 6,890 | In stock | |
| 100 mg | ¥ 9,350 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,230 | In stock |
FT895 相关产品
| 产品描述 | FT895 is a selective and potent HDAC11 inhibitor with antifungal and antitumor activity that inhibits HDAC11 expression and limits EV71 replication in vitro. |
| 靶点活性 | HDAC11:3 nM |
| 体外活性 | FT895是针对HDAC11的高度选择性抑制剂,对于其他10个HDAC家族成员的选择性超过1000倍[1]。 |
| 分子量 | 352.31 |
| 分子式 | C16H15F3N4O2 |
| CAS No. | 2225728-57-2 |
| Smiles | CC1(C)N(Cc2c1cccc2C(=O)NO)c1cnc(cn1)C(F)(F)F |
| 密度 | no data available |
| 存储 | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20 mg/mL (56.77 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.68 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容